Magnetic resonance spectroscopy (MRS) in the investigation of cancer at The Royal Marsden Hospital and The Institute of Cancer Research.
about
Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.Molecular imaging as a tool for translating breast cancer scienceResponse to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters.
P2860
Magnetic resonance spectroscopy (MRS) in the investigation of cancer at The Royal Marsden Hospital and The Institute of Cancer Research.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Magnetic resonance spectroscop ...... Institute of Cancer Research.
@ast
Magnetic resonance spectroscop ...... Institute of Cancer Research.
@en
type
label
Magnetic resonance spectroscop ...... Institute of Cancer Research.
@ast
Magnetic resonance spectroscop ...... Institute of Cancer Research.
@en
prefLabel
Magnetic resonance spectroscop ...... Institute of Cancer Research.
@ast
Magnetic resonance spectroscop ...... Institute of Cancer Research.
@en
P356
P1476
Magnetic resonance spectroscop ...... e Institute of Cancer Research
@en
P2093
P304
P356
10.1088/0031-9155/51/13/R05
P50
P577
2006-06-20T00:00:00Z